Vivimed Labs Limited Stock Price Today (NSE: VIVIMEDLAB)
Fundamental Score
Vivimed Labs Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Vivimed Labs Limited share price today is ₹5.38, down 1.65% on NSE/BSE as of 22 September 2026. Vivimed Labs Limited (VIVIMEDLAB) is a Small-cap company in the Unknown Industry sector with a market capitalisation of ₹8.92 (Cr). The 52-week high for VIVIMEDLAB share price is ₹7.21 and the 52-week low is ₹4.87.
Vivimed Labs Limited Share Price Chart — NSE/BSE Historical Performance
Vivimed Labs Limited share price chart: 22.91% return over the past month. 52-week high ₹7.21, 52-week low ₹4.87.
Vivimed Labs Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹5.47 | ₹5.69 | ₹5.47 | ₹5.47 | 10.64K (Cr) | |
| ₹5.71 | ₹5.78 | ₹5.58 | ₹5.58 | 16.76K (Cr) | |
| ₹5.69 | ₹5.80 | ₹5.69 | ₹5.69 | 37.93K (Cr) | |
| ₹5.81 | ₹5.89 | ₹5.80 | ₹5.80 | 5.07K (Cr) | |
| ₹6.03 | ₹6.03 | ₹5.91 | ₹5.91 | 3.46K (Cr) | |
| ₹6.03 | ₹6.03 | ₹6.03 | ₹6.03 | 21.89K (Cr) | |
| ₹6.39 | ₹6.39 | ₹6.15 | ₹6.15 | 31.61K (Cr) | |
| ₹6.35 | ₹6.40 | ₹6.21 | ₹6.27 | 50.63K (Cr) | |
| ₹6.42 | ₹6.42 | ₹6.33 | ₹6.33 | 19.39K (Cr) | |
| ₹6.51 | ₹6.51 | ₹6.45 | ₹6.45 | 43.69K (Cr) |
Vivimed Labs Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹6.80 | ₹6.80 | ₹5.47 | ₹5.47 | -19.56% | |
| ₹5.00 | ₹7.21 | ₹4.87 | ₹6.93 | +38.60% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Vivimed Labs Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Vivimed Labs Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VIVIMEDLAB across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Conservative Debt Levels (D/E: -1.89)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Risk Factors
6 factors identified
Suboptimal ROCE (-41.83%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Revenue Contraction (-53.15%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-39.47% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-41.03x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Liquidity Concerns (Current Ratio: 0.37)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Low Promoter Commitment (7.77%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Vivimed Labs Limited vs Sector Peers
Vivimed Labs Limited Quarterly Performance
Latest quarterly metrics for VIVIMEDLAB — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-53.15%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-39.47%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Vivimed Labs Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for VIVIMEDLAB — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Vivimed Labs Limited Financial Statements
Annual income statement, balance sheet and cash flow for Vivimed Labs Limited (VIVIMEDLAB) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Vivimed Labs Limited
About VIVIMEDLAB (Vivimed Labs Limited)
Vivimed Labs Limited (VIVIMEDLAB) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Unknown Industry sector with ...a current market capitalisation of ₹8.92 (Cr). The debt-to-equity ratio stands at -1.89, reflecting the company's capital structure. Investors tracking VIVIMEDLAB share price can monitor key metrics including P/E ratio, promoter holding of 7.77%, and quarterly earnings growth.
Company Details
VIVIMEDLAB Share Price: Frequently Asked Questions
What is the current share price of Vivimed Labs Limited?
Vivimed Labs Limited (VIVIMEDLAB) trades at ₹5.38 on NSE. Market cap ₹8.92 (Cr). Educational data only.
What is the P/E ratio of Vivimed Labs Limited?
Vivimed Labs Limited has a P/E of N/Ax vs industry average N/Ax.
What is the Bull Run score for Vivimed Labs Limited?
Vivimed Labs Limited has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Vivimed Labs Limited pay dividends?
Vivimed Labs Limited has a dividend yield of N/A. Past dividends don't guarantee future payments.
What is the ROE of Vivimed Labs Limited?
Vivimed Labs Limited has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Vivimed Labs Limited?
Vivimed Labs Limited has debt-to-equity of -1.89.
Is Vivimed Labs Limited a good investment?
Bull Run gives Vivimed Labs Limited a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.